Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

Similar articles for PubMed (Select 15557712)

1.

A case of marked hyperlipoprotein(a)emia associated with nephrotic syndrome and advanced atherosclerosis.

Kuge Y, Nozaki S, Kitagawa A, Inoue T, Otsuka H, Ito Y.

J Atheroscler Thromb. 2004;11(5):293-8.

2.

Hyperlipoprotein(a)aemia in nephrotic syndrome.

Thiery J, Ivandic B, Bahlmann G, Walli AK, Seidel D.

Eur J Clin Invest. 1996 Apr;26(4):316-21.

PMID:
8732490
3.

A young female with marked hyperlipoprotein(a)emia associated with nephrotic syndrome and stroke.

Kotani K, Kawano M.

J Atheroscler Thromb. 2005;12(4):234. No abstract available.

4.

Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.

Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P.

Miner Electrolyte Metab. 1996;22(1-3):26-30.

PMID:
8676820
5.

Elevated lipoprotein (a) levels in primary nephrotic syndrome.

Faucher C, Doucet C, Baumelou A, Chapman J, Jacobs C, Thillet J.

Am J Kidney Dis. 1993 Dec;22(6):808-13.

PMID:
8250027
6.

Lipoprotein(a) in nephrotic syndrome.

Stenvinkel P, Berglund L, Heimbürger O, Pettersson E, Alvestrand A.

Kidney Int. 1993 Nov;44(5):1116-23.

PMID:
8264144
7.

Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.

Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C.

Clin Chem. 1995 Jun;41(6 Pt 1):908-13.

8.

Elevated serum lipoprotein (a) levels associated with ulcerative colitis in a young Japanese patient.

Kawabata S, Katagiri S, Negoro H, Nogami A, Yabuuchi I, Gomi M, Arima R, Tarui S.

Intern Med. 1997 Jun;36(6):389-91.

9.

Serum lipoprotein (a) concentration in patients with nephrotic syndrome and its clinical implication.

Yang X, Wang H, Zhu Z, Deng A.

J Tongji Med Univ. 1998;18(4):236-8.

PMID:
10806854
11.

Lipoprotein(a) in nephrotic syndrome and end-stage renal disease.

Greiber S, Wanner C.

Miner Electrolyte Metab. 1997;23(3-6):161-5. Review.

PMID:
9387108
12.

[Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma].

Kolmakova EV, Shulutko BI, Shishkin AN.

Lik Sprava. 1992 Jun;(6):91-4. Russian.

PMID:
1455841
13.

Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.

Solfrizzi V, Capurso C, Colacicco AM, D'Introno A, Fontana C, Capurso SA, Torres F, Gadaleta AM, Koverech A, Capurso A, Panza F.

Atherosclerosis. 2006 Oct;188(2):455-61. Epub 2005 Dec 27.

PMID:
16384561
14.

Is lipoprotein(A) a risk factor for atherosclerosis of the retinal arteries?

Tedeschi-Reiner E, Reiner Z, Iveković R, Novak-Laus K.

Coll Antropol. 2002 Dec;26(2):609-14.

PMID:
12528289
15.

The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.

Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, König P, Thiery J, Koch M, von Eckardstein A, Dieplinger H.

Kidney Int. 2004 Feb;65(2):606-12.

PMID:
14717931
16.

Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.

Murase T, Okubo M, Amemiya-Kudo M, Hiraga T, Oka J, Shimada M, Igarashi T.

Metabolism. 2007 Sep;56(9):1187-91.

PMID:
17697860
17.

Severe hyperlipoproteinemia in congenital nephrotic syndrome of the Finnish type: effect of dialysis and kidney transplantation.

Salo MK, Jaakkola O, Solakivi T, Ylä-Herttuala S.

Acta Paediatr. 1993 Sep;82(9):768-72.

PMID:
8241675
18.

Lipoproteina(a) is a feature of the presence, diffuseness, and severity of coronary artery disease in Saudi population.

Habib SS, Abdel-Gader AM, Kurdi MI, Al-Aseri Z, Soliman MM.

Saudi Med J. 2009 Mar;30(3):346-52.

PMID:
19271061
19.

[The metabolic syndrome and hyper-Lp(a)-lipoproteinemia in peripheral obliterative atherosclerosis: 2 case reports].

Tesić D, Derić M, Ivković-Lazar T, Pantelinac P, Lepsanović L.

Med Pregl. 1996;49(7-8):313-7. Croatian.

PMID:
8926951
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk